A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain
- First Posted Date
- 2015-04-09
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- TheraVasc Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT02412852
- Locations
- 🇺🇸
Ohio Pain Clinic, Centerville, Ohio, United States
Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- TheraVasc Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT01401517
- Locations
- 🇺🇸
University of Colorado Denver Health Sciences Center, Aurora, Colorado, United States
🇺🇸Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
© Copyright 2025. All Rights Reserved by MedPath